Insider Transactions in Q4 2022 at Replimune Group, Inc. (REPL)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 09
2022
|
Pamela Esposito Chief Business Officer |
SELL
Open market or private sale
|
Direct |
15,000
-6.14%
|
$375,000
$25.03 P/Share
|
|
Dec 09
2022
|
Pamela Esposito Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+5.78%
|
$15,000
$1.01 P/Share
|
|
Dec 01
2022
|
Konstantinos Xynos Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,500
+19.82%
|
-
|